Ronald S. Go, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Ronald S. Go, MD

Ronald S. Go, MD

Healthcare Professional
Chair
Core Consultative
Hematology Disease-Oriented Group
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Ronald S. Go earned his degree in Medicine from the University of Santo Tomas, College of Science. He completed his Residency in Internal Medicine at Baylor College of Medicine and a Fellowship in Hematology and Oncology at Mayo Clinic Division of Hematology/Oncology. Currently, he is associated as a Consultant in the Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Dr. Go’s areas of interests are amyloidosis, Erdheim-Chester disease, health services and outcomes research, large granular lymphocyte leukemia, multiple myeloma and non-malignant hematology.

Dr. Go engages in health services research, including studies on populations’ access to and cost of care, utilization of tests and treatments, and outcome and quality of care. Dr. Go also investigates on the pathogenesis, diagnosis and treatment of histiocytic disorders such as Erdheim-Chester disease, Rosai-Dorfman disease and Langerhans cell histiocytosis as well as complement-mediated hematologic conditions such as Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, etc.

 

Representative Publications:

Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopenia

Natural history of multiple myeloma with de novo del(17p)

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close